经尿道前列腺等离子剜除术治疗高龄高危前列腺增生的疗效  

Efficacy of Transurethral Enucleation of the Prostate with Plasma Enucleation in the Treatment of Advanced and High-risk Benign Prostatic Hyperplasia

作　　者：周业茂 ZHOU Yemao(Department of Urology,Xinyi Traditional Chinese Medicine Hospital,Xinyi,Jiangsu Province,221400 China)

机构地区：[1]新沂市中医医院泌尿外科,江苏新沂221400

出　　处：《中外医疗》2022年第14期71-74,共4页China & Foreign Medical Treatment

摘　　要：目的分析予以高龄高危前列腺增生患者经尿道前列腺等离子剜除术治疗的临床效果。方法方便选择该院2018年2月—2021年12月收治的45例高龄高危前列腺增生患者为研究对象,应用数字随机表形式将其均分对照组(20例,采取经尿道等离子前列腺电切术治疗),观察组(25例,采取经尿道前列腺等离子剜除术治疗)。对比两组围术期指标、预后指标、生活质量及并发症发生率。结果观察组术中出血量、腺体组织切除量、手术时间、膀胱冲洗时间、住院时间分别为(76.49±14.56)mL、(52.36±13.82)g、(53.80±11.42)min、(20.25±8.37)h、(6.26±1.52)d,均优于对照组的(125.76±15.41)mL、(35.46±11.35)g、(66.92±10.28)min、(30.50±9.55)h、(8.58±2.21)d,差异有统计学意义(t=10.992、4.405、4.001、3.834、4.165,P<0.05)。观察组PVR、Qmax、IPSS分别为(15.05±1.34)mL、(17.48±1.25)mL/s、(7.33±1.25)分,均优于对照组的(27.52±2.66)mL、(13.52±1.42)mL/s、(11.56±1.44)分,差异有统计学意义(t=20.457、9.941、10.544,P<0.05)。观察组两组生活质量(QOL评分)为(2.75±0.16)分,低于对照组的(3.12±0.20)分,差异有统计学意义(t=6.899,P<0.05)。观察组并发症发生率(4.00%)对比对照组(30.00%)有明显降低,差异有统计学意义(χ^(2)=3.910,P<0.05)。结论予以高龄高危前列腺增生患者经尿道前列腺等离子剜除术治疗效果确切,安全有效,可行推广。Objective To analyze the clinical effect of transurethral enucleation of the prostate in elderly patients with high-risk benign prostatic hyperplasia.Methods A total of 45 elderly patients with high-risk benign prostatic hyperplasia who were treated in this hospital from February 2018 to December 2021 were conveniently selected as the research objects,and they were equally divided into the control group(20 cases,treated by transurethral plasma resection of the prostate),the observation group(25 cases,taking transurethral enucleation of prostate plasma treatment)by means of a digital random table.The perioperative indicators,prognostic indicators,quality of life and complication rates were compared between the two groups.Results The intraoperative blood loss,amount of glandular tissue removal,operation time,bladder irrigation time,hospitalization time of the observation group were(76.49±14.56)mL,(52.36±13.82)g,(53.80±11.42)min,(20.25±8.37)h,(6.26±1.52)d,which were all better than those of the control group(125.76±15.41)mL,(35.46±11.35)g,(66.92±10.28)min,(30.50±9.55)h,(8.58±2.21)d,the differences were statistically significant(t=10.992,4.405,4.001,3.834,4.165,P<0.05).The PVR,Qmax,IPSS in the observation group were(15.05±1.34)mL,(17.48±1.25)mL/s,and(7.33±1.25)points,which were better than those in the control group(27.52±2.66)mL,(13.52±1.42)mL/s,(11.56±1.44)points,the difference was statistically significant(t=20.457,9.941,10.544,P<0.05).The quality of life(QOL score)in the observation group was(2.75±0.16)points,which was lower than that in the control group(3.12±0.20)points,and the difference was statistically significant(t=6.899,P<0.05).The incidence of complications in the observation group(4.00%)was significantly lower than that in the control group(30.00%),and the difference was statistically significant(χ^(2)=3.910,P<0.05).Conclusion Transurethral enucleation of the prostate in elderly patients with high-risk benign prostatic hyperplasia is effective,safe and effective,and can be promoted.

关 键 词：高龄高危患者 前列腺增生 经尿道前列腺等离子剜除术 

分 类 号：R699[医药卫生—泌尿科学]